InvestorsHub Logo
Followers 2
Posts 72
Boards Moderated 0
Alias Born 11/23/2020

Re: None

Wednesday, 12/30/2020 10:07:17 AM

Wednesday, December 30, 2020 10:07:17 AM

Post# of 36630
Why is everyone thinking we will get trial data any day now?
Their last PR (23.dec) stated that they haven´t met the enrollment goal yet.
Or am I wrong?

"...clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19. The Company is on pace to meet its enrollment goals for the Independent Data and Safety Monitoring Board (“DSMB”) to review the safety and efficacy data from the 210 patients as part of the first interim analysis of patients treated and followed up for 28 days after randomization..."

I've got all the best cognition, with all the top grammar ;)